PHOENIX-HNSCC
Recruiting
99 years or below
All
Phase
N/A
20 participants needed
Brief description of study
- PURPOSE
- To create a robust multi-omic dataset composed of rich molecular and clinical data for metastatic or unresectable, recurrent HNSCC patients who receive standard of care immune checkpoint inhibitors therapy for the purposes of understanding the relationship between biomarkers and real-world outcomes of standard of care therapies. The primary objective of this study is to determine whether the genetic makeup of blood samples and tumor tissue of patients with metastatic or unresectable, recurrent HNSCC changes over time. The secondary objective of this study is to review relevant medical information of patients with metastatic or unresectable, recurrent HNSCC to potentially improve future treatment decisions and general health outcomes.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
16 Dec 2024.
Study ID: 857214
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
